-
-
-
-
-
-
-
Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
-
-
-
-
-
-
-
Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion
-
-
-
-
-
-
-
Takeda Delivers Strong Revenue and Profit Growth in FY2022; Updated Capital Allocation Policy Reflects Deleveraging Progress and Confidence in Growth Outlook
-
-
-
-
-
-
-
Takeda Delivers Strong FY2021 Results; Continued Growth Momentum Expected in FY2022
-
-
-
-
-
-
-
Centogene N.V. (CNTG) Extends Partnership With Takeda (TAK)
-
-
-
-
-
-
-
Takeda Announces FY2020 Q1 Results; Confirms Management Guidance & Raises Reported Operating Profit And Reported Net Profit for the Full Year
-
-
-
-
-
-
-
Takeda Reports Solid Second Quarter FY2019 Results and Raises Profit Guidance for the Full Year
-
1,216,204 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

